https://wikimd.org/index.php?action=history&feed=atom&title=Ro_19-4603Ro 19-4603 - Revision history2026-04-27T14:05:53ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.org/index.php?title=Ro_19-4603&diff=6416347&oldid=prevPrab: CSV import2025-03-03T05:26:12Z<p>CSV import</p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 05:26, 3 March 2025</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l23">Line 23:</td>
<td colspan="2" class="diff-lineno">Line 23:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Unmarketed drugs]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Unmarketed drugs]]</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{pharmacology-stub}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{pharmacology-stub}}</div></td></tr>
<tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"><gallery></ins></div></td></tr>
<tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">File:Ro 19-4603.svg|Ro 19-4603</ins></div></td></tr>
<tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></gallery></ins></div></td></tr>
</table>Prabhttps://wikimd.org/index.php?title=Ro_19-4603&diff=5370833&oldid=prevPrab: CSV import2024-03-06T20:22:16Z<p>CSV import</p>
<p><b>New page</b></p><div>'''Ro 19-4603''' is a [[benzodiazepine]] derivative drug, which is a class of drugs used primarily for their [[psychoactive]] properties. It was developed by the pharmaceutical company [[Hoffmann-La Roche]] in the 1980s. Ro 19-4603 is notable for its unique [[pharmacological]] profile, differing significantly from other drugs in the benzodiazepine class.<br />
<br />
==Pharmacology==<br />
Ro 19-4603 is a [[partial agonist]] at the [[GABA_A receptor]], the primary inhibitory [[neurotransmitter receptor]] in the brain. This means that it can both activate the receptor to produce a response and also block the receptor to prevent a response. This dual action is thought to contribute to the drug's unique effects.<br />
<br />
Unlike most benzodiazepines, which are full agonists at the GABA_A receptor, Ro 19-4603 does not produce significant [[sedative]] or [[muscle relaxant]] effects. Instead, it has been found to have [[anxiolytic]] (anti-anxiety) and [[anticonvulsant]] (anti-seizure) properties. This makes it potentially useful for the treatment of conditions such as [[anxiety disorders]] and [[epilepsy]].<br />
<br />
==Development and Research==<br />
Ro 19-4603 was developed by [[Hoffmann-La Roche]] in the 1980s as part of their ongoing research into benzodiazepine derivatives. Despite its promising pharmacological profile, the drug was never marketed. The reasons for this are not clear, but may relate to the complex regulatory environment for new drugs, as well as the availability of other effective treatments for anxiety and epilepsy.<br />
<br />
Research into Ro 19-4603 has provided valuable insights into the workings of the GABA_A receptor and the effects of different types of agonists. This has helped to inform the development of other drugs and to improve our understanding of [[neuropharmacology]].<br />
<br />
==See Also==<br />
* [[Benzodiazepine]]<br />
* [[GABA_A receptor]]<br />
* [[Hoffmann-La Roche]]<br />
<br />
==References==<br />
<references /><br />
<br />
[[Category:Pharmacology]]<br />
[[Category:Benzodiazepines]]<br />
[[Category:Unmarketed drugs]]<br />
{{pharmacology-stub}}</div>Prab